CELLUGY

Their core work

CELLUGY is a Danish biotech SME developing nanocellulose-based biodegradable materials to replace petroleum-derived plastic barrier coatings in packaging. Their core technology uses microbial biotechnology and industrial microbiology to produce nanocellulose — likely from agricultural or food-processing waste streams such as fruit residues — and processes it into thin films and coatings with functional barrier properties. Their commercial focus is on providing the packaging industry with a drop-in alternative to synthetic polymer coatings, targeting the circular economy transition in food and consumer packaging. They operate at the applied end of the R&D spectrum, having moved from concept validation to funded product development within a two-year window.

What they specialise in

How they've shifted over time

CELLUGY's H2020 record covers a tight two-year window (2019–2021 project starts), so there is no long-term keyword shift to analyse in the traditional sense. What the data does show is a clear progression from concept to development: the 2019 Phase 1 project carried no recorded keywords beyond the project title, reflecting its short feasibility-study nature, while the 2021 Phase 2 project is rich with technical descriptors spanning microbial biotechnology, nanomaterials, bioeconomy, and coating applications. This is not a change in direction but a deepening of a single focused technology — the organisation identified its niche early and went straight into scaling it. The trajectory is linear and committed: from proof-of-concept in fruit-waste bioplastic film toward a commercially viable nanocellulose coating product.

CELLUGY is scaling a single well-defined technology toward market entry — organisations looking for a partner at the plastic-free packaging frontier will find them at the applied development stage, ready for industrial pilots rather than basic research.

How they like to work

CELLUGY has participated exclusively through the SME Instrument, which by design does not require a consortium — both of their projects were led and executed as the sole beneficiary. This means there is no evidence of collaborative R&D behaviour within their H2020 record; they operate as an autonomous innovator rather than a consortium builder. For a future partner, this signals a company focused on proprietary technology development that is more likely to engage in bilateral technology licensing, supply agreements, or industry-pilot partnerships than in large multi-partner EU project consortia.

CELLUGY has no recorded consortium partners in their H2020 data, which is expected given the solo-SME-Instrument format they used. Their network, while not visible through EU project data, almost certainly includes packaging industry contacts and academic collaborators accessed outside formal consortium structures.

What sets them apart

CELLUGY occupies a specific and commercially valuable niche: they are not a materials research institute producing nanocellulose as a scientific curiosity, but a product company engineering it into a functional coating that packaging manufacturers can adopt. Their microbial production route — rather than the more common mechanical or chemical pulp extraction — may give them a cost or feedstock flexibility advantage. For any consortium or company needing a credible, EU-funded SME with a commercially oriented nanocellulose technology and a track record of advancing from feasibility to near-market development, CELLUGY is a rare find in the Nordic bioeconomy space.

Highlights from their portfolio

• EcoFLEXY (Phase 2)
  The largest of CELLUGY's two projects at EUR 2.38M (SME Instrument Phase 2), representing a full EU validation of their technology readiness and commercial potential in biodegradable barrier coatings.
• EcoFLEXY (Phase 1)
  The EUR 50,000 feasibility grant that confirmed the concept of producing nanocellulose bioplastic film from fruit waste, directly unlocking the Phase 2 scale-up investment.